Regeneron Pharmaceuticals Net Income Over Time

REGN Stock  USD 966.30  2.75  0.29%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Regeneron Pharmaceuticals Performance and Regeneron Pharmaceuticals Correlation.
To learn how to invest in Regeneron Stock, please use our How to Invest in Regeneron Pharmaceuticals guide.
  
At this time, Regeneron Pharmaceuticals' Net Income is very stable compared to the past year. As of the 28th of March 2024, Net Income Applicable To Common Shares is likely to grow to about 5.2 B, while Net Income From Continuing Ops is likely to drop about 2.2 B.
Is Regeneron Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Regeneron Pharmaceuticals. If investors know Regeneron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Regeneron Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.03)
Earnings Share
34.78
Revenue Per Share
122.935
Quarterly Revenue Growth
0.006
Return On Assets
0.0849
The market value of Regeneron Pharmaceuticals is measured differently than its book value, which is the value of Regeneron that is recorded on the company's balance sheet. Investors also form their own opinion of Regeneron Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Regeneron Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Regeneron Pharmaceuticals' market value can be influenced by many factors that don't directly affect Regeneron Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Regeneron Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Regeneron Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Regeneron Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:

Cross Equities Net Income Analysis

Compare Regeneron Pharmaceuticals and related stocks such as Agilent Technologies, Moleculin Biotech, and Clever Leaves Holdings Net Income Over Time
Select Fundamental
201020112012201320142015201620172018201920202021202220232024
A257 M1.2 B724 M497 M398 M460 M684 M316 M1.1 B719 M1.2 B1.3 B1.2 B1.4 B1.5 B
MBRX(365.8 K)(365.8 K)(365.8 K)(365.8 K)(365.8 K)(365.8 K)(3.9 M)(9.8 M)(11.9 M)(13.2 M)(15 M)(8.9 M)(27.4 M)(29.8 M)(28.3 M)
CLVRW(48.1 M)(48.1 M)(48.1 M)(48.1 M)(48.1 M)(48.1 M)(48.1 M)(48.1 M)(48.1 M)(48.1 M)(41.4 M)(45.6 M)(66.1 M)(41.6 M)(43.7 M)
EQ(2.3 M)(2.3 M)(2.3 M)(2.3 M)(2.3 M)(2.3 M)(2.3 M)(2.3 M)(13.2 M)(25.6 M)(29.8 M)(39 M)(107.7 M)(13.3 M)(14 M)
KA(59.1 M)(59.1 M)(59.1 M)(59.1 M)(59.1 M)(59.1 M)(59.1 M)(59.1 M)(59.1 M)(59.1 M)(13.9 M)(12 M)(63.1 M)(14.1 M)(14.8 M)
MDWD(6.2 M)(6.2 M)10.9 M(15.4 M)(18.9 M)(22.1 M)(18.9 M)(22.1 M)(1.1 M)3.7 M(9.6 M)(13.6 M)(19.6 M)(6.7 M)(7.1 M)

Regeneron Pharmaceuticals and related stocks such as Agilent Technologies, Moleculin Biotech, and Clever Leaves Holdings Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Regeneron Pharmaceuticals financial statement analysis. It represents the amount of money remaining after all of Regeneron Pharmaceuticals operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

My Equities

My Current Equities and Potential Positions

Regeneron Pharmaceuticals
REGN
Regeneron Pharmaceuticals Fama & French Biotech
Biotech
Fama & French Classification
RegionNorth America
ExchangeNASDAQ Exchange
USD 966.3
When determining whether Regeneron Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Regeneron Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Regeneron Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Regeneron Pharmaceuticals Stock:
Check out Regeneron Pharmaceuticals Performance and Regeneron Pharmaceuticals Correlation.
To learn how to invest in Regeneron Stock, please use our How to Invest in Regeneron Pharmaceuticals guide.
Note that the Regeneron Pharmaceuticals information on this page should be used as a complementary analysis to other Regeneron Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Complementary Tools for Regeneron Stock analysis

When running Regeneron Pharmaceuticals' price analysis, check to measure Regeneron Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regeneron Pharmaceuticals is operating at the current time. Most of Regeneron Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Regeneron Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regeneron Pharmaceuticals' price. Additionally, you may evaluate how the addition of Regeneron Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Regeneron Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Regeneron Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Regeneron Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...